The Value of a Structural Heart Program: Impact Beyond the Procedure

Despite its breakthrough approach and clinical success, TAVR is often perceived as economically unsustainable due to limited reimbursement in relation to its resource intensive, high-acuity patient population. This CV business white paper highlights key insights from Baylor Scott & White Health’s analysis of the far-reaching impact and patient loyalty effects of their TAVR program beyond the procedure itself. Often referred to as the “halo effect,” quantifying adjunct revenues is critical for organizations seeking a holistic understanding of their structural heart service line to foster adoption of new and innovative therapies.  

ACCESS CV BUSINESS WHITE PAPER